Human microdosing for the prediction of patient response

Por Henderson, Paul T, Pan, Chong-xian
Publicado em 2010

Progress in Personalizing Chemotherapy for Bladder Cancer

Por Chang, James S., Lara, Primo N., Pan, Chong-Xian
Publicado em 2012

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer

Por Cimino, George D, Pan, Chong-xian, Henderson, Paul T
Publicado em 2013

Contemporary management of muscle-invasive bladder cancer

Por Dall’Era, Marc A, Cheng, Liang, Pan, Chong-Xian
Publicado em 2012

Nanotechnology in bladder cancer: current state of development and clinical practice

Por Tomlinson, Ben, Lin, Tzu-yin, Dall'Era, Marc, Pan, Chong-Xian
Publicado no Nanomedicine (Lond) (2015)

Analysis of the Cytotoxic Activity of the Carboplatin and Gemcitabine Combination

Por Wang, Sisi, Zhang, Hongyong, Cheng, Liang, Evans, Christopher, Pan, Chong-Xian
Publicado no Anticancer Res (2010)

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

Por Zhang, Hongyong, Luo, Juntao, Li, Yuanpei, Henderson, Paul T, Wachsmann-Hogiu, Sebastian, Lam, Kit S., Pan, Chong-xian
Publicado no Nanomedicine (2011)

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Por Wang, Yu, Mikhailova, Margarita, Bose, Swagata, Pan, Chong-Xian, deVere White, Ralph W., Ghosh, Paramita M.
Publicado em 2008

Feasibility Study of Intra-patient Sorafenib Dose-Escalation or Re-Escalation in Patients with Previously Treated Advanced Solid Tumors

Por Semrad, Thomas J., Eddings, Courtney, Pan, Chong-Xian, Lau, Derick H., Gandara, David, Beckett, Laurel, Lara, Primo N.
Publicado em 2011

Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity

Por Jiang, Shuai, Pan, Amy W., Lin, Tzu-yin, Zhang, Hongyong, Malfatti, Michael, Turteltaub, Kenneth, Henderson, Paul T., Pan, Chong-xian
Publicado no Chem Res Toxicol (2015)

Determinants of survival in adolescents and young adults with urothelial bladder cancer: results from the California Cancer Registry

Por Lara, Joshua, Brunson, Ann, Keegan, Theresa H.M., Malogolowkin, Marcio, Pan, Chong-Xian, Yap, Stanley, deVere White, Ralph
Publicado no J Urol (2016)

Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells

Por Wang, Sisi, Zhang, Hongyong, Malfatti, Michael, de Vere White, Ralph, Lara, Primo N., Turteltaub, Kenneth, Henderson, Paul, Pan, Chong-xian
Publicado em 2010

Prospective Evaluation of Low-Dose Ketoconazole Plus Hydrocortisone (HC) in Docetaxel Pre-treated Castration-Resistant Prostate Cancer (CRPC) Patients

Por Lo, Ernest N., Beckett, Laurel A., Pan, Chong-Xian, Robles, Daniel, Suga, Jennifer M., Sands, Jacob M., Lara, Primo N.
Publicado no Prostate Cancer Prostatic Dis (2015)

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

Por Lin, Tzu-yin, Zhang, Hongyong, Wang, Sisi, Xie, Li, Li, Bin, Rodriguez, Carlos O, de Vere White, Ralph, Pan, Chong-xian
Publicado em 2011

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer

Por Lin, Tzu-yin, Zhang, Hongyong, Luo, Juntao, Li, Yuanpei, Gao, Tingjuan, Lara, Primo N, de Vere White, Ralph, Lam, Kit S, Pan, Chong-Xian
Publicado em 2012

Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer

Por Lin, Tzu-yin, Li, Yuan-Pei, Zhang, Hongyong, Luo, Juntao, Goodwin, Neal, Gao, Tingjuan, de Vere White, Ralph, Lam, Kit S, Pan, Chong-Xian
Publicado em 2012

Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach

Por Zhang, Hongyong, Aina, Olulanu H., Lam, Kit S., de Vere White, Ralph, Evans, Christopher, Henderson, Paul, Lara, Primo N., Wang, Xiaobing, Bassuk, James A., Pan, Chong-xian
Publicado no Urol Oncol (2010)

A diagnostic microdosing approach to study gemcitabine resistance

Por Scharadin, Tiffany M., Zhang, Hongyong, Zimmermann, Maike, Wang, Sisi, Malfatti, Michael A., Cimino, George D., Turteltaub, Kenneth, de Vere White, Ralph, Pan, Chong-xian, Henderson, Paul T.
Publicado no Chem Res Toxicol (2016)

Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin

Por Zhang, Hongyong, Li, Yuanpei, Lin, Tzu-yin, Xiao, Kai, Haddad, Ashraf S, Henderson, Paul T, Jonas, Brian A, Chen, Mingyi, Xiao, Wenwu, Liu, Ruiwu, Lam, Kit S, Pan, Chong-xian
Publicado em 2014

Phase II Study of Erlotinib in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer: SWOG S0317

Por Gordon, Michael S., Hussey, Michael, Nagle, Raymond B., Lara, Primo N., Mack, Philip C., Dutcher, Janice, Samlowski, Wolfram, Clark, Joseph I., Quinn, David I., Pan, Chong-Xian, Crawford, David
Publicado em 2009